Park Ha Biological Technology Co., Ltd. (BYAH) vs The Procter & Gamble Company (PG)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| BYAH | PG | |
|---|---|---|
| Sector | Consumer Defensive | Consumer Defensive |
| Industry | Household & Personal Products | Household & Personal Products |
| Size band | NANO | MEGA |
| Listing | Nasdaq CM | NYSE |
| Country | China | United States |
| Theme | beauty-and-personal-care | household-products |
| Price and returns | ||
| Last close | $2.19 | $159.92 |
| Return · 1 week | −2.67% | +2.09% |
| Return · 1 month | −9.13% | +7.31% |
| Return · 3 months | −23.10% | +7.42% |
| Return · year to date | −74.24% | +14.44% |
| Return · 1 year | −88.62% | +6.94% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −89.67% | −4.38% |
| 52-week high | $21.20 | $167.25 |
| 52-week low | $0.37 | $137.62 |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $42.73M | $370.66B |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $90.56K | $1.29B |
| Employees | 41 | 104,000 |
| Valuation | ||
| Price to earnings · trailing | n/a (negative earnings) | 24.07× |
| Price to earnings · forward | — | 21.56× |
| Price to sales | 17.80× | 4.26× |
| Price to book | 0.27× | 6.94× |
| Enterprise value to EBITDA | n/a (negative enterprise value and EBITDA) | 16.02× |
| Enterprise value to revenue | n/a (negative enterprise value) | 4.56× |
| PEG ratio | — | 4.08 |
| Earnings per share · trailing | -37.68 | 6.62 |
| Profitability | ||
| Gross margin | 94.36% | 50.18% |
| Operating margin | −76.53% | 22.08% |
| Profit margin | −214.17% | 18.10% |
| Return on equity | −113.04% | 30.29% |
| Return on assets | −50.74% | 10.72% |
| Growth | ||
| Revenue growth | +1.50% | +1.50% |
| Earnings growth | — | −15.50% |
| Balance sheet and payout | ||
| Debt / equity (%) | 3.46 | 64.49 |
| Current ratio | 3.37 | 0.68 |
| Dividend yield | 0.00% | 2.73% |
| Payout ratio | 0.00% | 64.33% |
| Trend and volatility | ||
| RSI · 14 | 42.12 | 61.34 |
| ADX · 14 | 56.58 | 34.41 |
| 50-day average | $2.54 | $148.67 |
| 200-day average | $2.25 | $148.61 |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 12.79% | 2.07% |
The full BYAH analysis
Everything this table leaves out for Park Ha Biological Technology Co., Ltd.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the BYAH argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full BYAH analysisThe full PG analysis
Everything this table leaves out for The Procter & Gamble Company: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the PG argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full PG analysis